HomeGlossary › ROE

ROE (Return on Equity): Definition, Formula & DuPont Analysis

Return on Equity (ROE) — ROE measures how much net income a company generates for each dollar of shareholders’ equity. It answers the core question every equity investor should ask: how efficiently is management turning my capital into profit?

The ROE Formula

Return on Equity ROE = Net Income ÷ Average Shareholders’ Equity

Use average equity (beginning + ending, divided by 2) rather than a single point-in-time figure. This smooths out the effect of equity changes during the year — buybacks, new issuances, or large swings in retained earnings.

If a company earned $3 billion in net income on average shareholders’ equity of $15 billion, its ROE is 20%. For every dollar of equity, management generated 20 cents of profit.

What Is a Good ROE?

ROE RangeInterpretation
Below 8%Below the cost of equity for most companies — value may be destroyed
8%–12%Adequate — roughly in line with the long-term equity cost of capital
12%–20%Strong — the company is earning well above its cost of equity
Above 20%Exceptional — often signals a competitive moat or capital-light model
Above 40%Verify the source — may be driven by extreme leverage or thin equity base

The S&P 500 median ROE typically falls in the 13%–17% range. But sector matters enormously — tech companies routinely post 25%+ ROE, while capital-intensive utilities may hover around 9%–11%. Always benchmark against industry peers.

The DuPont Analysis: Breaking ROE Apart

A single ROE number hides a lot. Two companies can both show 18% ROE but get there through completely different paths. The DuPont framework decomposes ROE into three drivers:

DuPont Three-Factor Model ROE = Net Profit Margin × Asset Turnover × Equity Multiplier
ComponentFormulaWhat It Reveals
Net Profit MarginNet Income ÷ RevenueHow much of each revenue dollar becomes profit
Asset TurnoverRevenue ÷ Total AssetsHow efficiently assets generate revenue
Equity MultiplierTotal Assets ÷ Shareholders’ EquityHow much leverage the company uses (higher = more debt)

This is where the real insight lives. Consider two companies with identical 20% ROE:

CompanyNet MarginAsset TurnoverEquity MultiplierROE
Company A20%0.5x2.0x20%
Company B5%1.0x4.0x20%

Company A earns its ROE through high margins. Company B earns the same ROE through aggressive leverage (4x equity multiplier). Same headline number, vastly different risk profiles. If interest rates rise or credit tightens, Company B’s ROE will compress far more violently. The DuPont breakdown tells you where the returns come from — and which ones are sustainable.

Analyst Tip
Track DuPont components over 5+ years. If ROE is stable but the equity multiplier is climbing, the company is maintaining returns by taking on more debt — not by improving operations. That’s a deteriorating trend hidden behind a steady headline number.

How to Use ROE in Practice

Quality screen. Consistently high ROE (15%+ over 5–10 years) is one of the strongest signals of a durable competitive advantage. Companies like this are compounding shareholder value — each retained dollar earns above the cost of equity, creating economic profit.

Pair with P/B ratio. ROE and P/B are two sides of the same coin. A high P/B is justified when ROE is high. A company trading at 4x book with 25% ROE might be a better deal than one at 1.5x book with 7% ROE. Check both together — always.

Compare retained vs. distributed earnings. ROE tells you what a company earns on its equity. If ROE is 20% and the company retains 70% of earnings, it’s reinvesting that capital at 20% returns. That’s powerful compounding. If ROE is only 8%, shareholders might be better off getting those earnings as dividends rather than having them reinvested at mediocre rates.

Watch the trend. A declining ROE demands investigation. Is it margin compression? Slower asset turnover? Rising leverage that’s no longer translating to profits? The DuPont decomposition will show you exactly which lever is moving.

ROE vs. ROIC vs. ROA

ROE, ROIC, and ROA all measure profitability relative to capital — but they look at different slices:

MetricNumeratorDenominatorWhat It Captures
ROENet IncomeShareholders’ EquityReturn to equity holders — affected by leverage
ROICNOPAT (after-tax operating profit)Invested CapitalReturn on all invested capital — leverage-neutral
ROANet IncomeTotal AssetsHow efficiently all assets generate profit

ROE is the metric equity investors care about most. But because leverage inflates ROE, always cross-check with ROIC — which strips out the capital structure effect — to see whether the underlying business is genuinely earning high returns, or just using financial engineering.

Limitations of ROE

Leverage flatters ROE. This is the single biggest trap. A company can boost ROE simply by taking on more debt — which shrinks the equity denominator. High ROE driven by leverage isn’t the same as high ROE driven by operational excellence. The DuPont analysis or a direct comparison to ROIC will expose this immediately.

Negative equity distorts the math. Companies with negative shareholders’ equity (from accumulated losses or aggressive buybacks) produce meaningless ROE figures. A company earning positive net income on negative equity shows a negative ROE — which is technically wrong since the business is profitable.

Net income is noisy. One-time gains, write-downs, tax windfalls, and accounting elections all flow through to the bottom line. A single year’s ROE can be heavily distorted. Use a 3–5 year average, or calculate ROE from normalized earnings.

Backward-looking. ROE reflects past performance. A company’s competitive position, margin trajectory, and reinvestment opportunities can shift faster than trailing ROE suggests. Always pair historical ROE with a forward-looking assessment of competitive dynamics.

Key Takeaways

  • ROE = net income ÷ average shareholders’ equity. It measures how well a company converts equity capital into profit.
  • Use the DuPont breakdown (margin × turnover × leverage) to understand why ROE is high or low.
  • Consistently high ROE (15%+) is one of the best indicators of a durable competitive moat.
  • Leverage inflates ROE — always cross-check with ROIC or the debt-to-equity ratio to separate operational quality from financial engineering.
  • Pair ROE with P/B ratio to assess whether you’re paying a fair price for the returns being generated.

Frequently Asked Questions

Why is ROE important for investors?

ROE directly measures the return being generated on your capital as a shareholder. A company with 20% ROE that retains its earnings is compounding your investment at 20% per year (before the market revalues the stock). It’s the clearest metric for assessing whether management is creating or destroying value with the equity entrusted to them.

Can ROE be too high?

Extremely high ROE (40%+) isn’t necessarily bad, but it warrants investigation. It can be driven by genuinely exceptional economics (capital-light models with massive margins), but it can also result from excessive leverage, a very thin equity base due to share buybacks, or one-time earnings events. Run the DuPont decomposition to check whether the equity multiplier is the primary driver — if so, the “high return” carries proportionally higher financial risk.

What’s the difference between ROE and ROA?

ROA measures returns on total assets (both equity and debt-funded), while ROE measures returns only on the equity portion. The gap between the two reveals the effect of leverage. If a company has 15% ROE and 5% ROA, the difference is almost entirely due to debt financing. ROA gives a purer view of operational efficiency; ROE shows what equity holders actually earn.

How does ROE relate to stock returns?

Over the long term, a stock’s total return tends to converge toward its ROE multiplied by its retention rate (the portion of earnings reinvested rather than paid as dividends). A company with 20% ROE that retains 75% of earnings is growing its equity base at roughly 15% per year — which, all else equal, should translate into similar long-term stock price appreciation. This is why compounders with high, stable ROE tend to outperform over decades.